Efficacy of nivolumab and temozolomide in advanced neuroendocrine neoplasms (NENs) in a phase 2 clinical trial.

被引：0
|
作者：
Owen, Dwight Hall
Benner, Brooke
Wei, Lai
Sukrithan, Vineeth
Goyal, Ashima
Zhou, Ye
Suffren, Sheryl-Ann
Pilcher, Carly
Christenson, Gwen
Curtis, Nancy
Savardekar, Himanshu
Norman, Ruthann
Ferguson, Sarah
Kleiber, Barbara
Wesolowski, Robert
Carson, William Edgar
Otterson, Gregory Alan
Verschraegen, Claire F.
Shah, Manisha H.
Konda, Bhavana
机构：
[1] Ohio State Univ, Div Med Oncol, Dept Internal Med, Columbus, OH USA
[2] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[3] Ohio State Univ, Ctr Biostatist, Columbus, OH USA
[4] Ohio State Univ, Div Med Oncol, Dept Internal Med, Comprehens Canc Ctr, Columbus, OH USA
[5] Ohio State Univ, Columbus, OH USA
[6] James Canc Hosp, Columbus, OH USA
[7] Ohio State Univ, Wexner Med Ctr, Hilliard, OH USA
[8] Ohio State Univ, Div Med Oncol, Comprehens Canc Ctr, Columbus, OH USA
[9] Ohio State Univ, Dept Surg, Comprehens Canc Ctr, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4121
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
    Owen, Dwight H.
    Benner, Brooke
    Wei, Lai
    Sukrithan, Vineeth
    Goyal, Ashima
    Zhou, Ye
    Pilcher, Carly
    Suffren, Sheryl -Ann
    Christenson, Gwen
    Curtis, Nancy
    Jukich, Megan
    Schwarz, Emily
    Savardekar, Himanshu
    Norman, Ruthann
    Ferguson, Sarah
    Kleiber, Barbara
    Wesolowski, Robert
    Carson III, William E.
    Otterson, Gregory A.
    Verschraegen, Claire F.
    Shah, Manisha H.
    Konda, Bhavana
    CLINICAL CANCER RESEARCH, 2023, 29 (04) : 731 - 741
  • [2] Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
    Thomas, Katharine
    Voros, Brianne A.
    Meadows-Taylor, Meghan
    Smeltzer, Matthew P.
    Griffin, Ryan
    Boudreaux, J. Philip
    Thiagarajan, Ramcharan
    Woltering, Eugene A.
    Ramirez, Robert A.
    CANCERS, 2020, 12 (01)
  • [3] Association of LAG-3 expression in circulating T cells and response to combination temozolomide (TMZ) and nivolumab (NIVO) in advanced neuroendocrine neoplasms (NENs): Results from an investigator-initiated phase 2 trial.
    Sukrithan, Vineeth
    Benner, Brooke
    Wei, Lai
    Goyal, Ashima
    Zhou, Ye
    Suffren, Sheryl-Ann
    Pilcher, Carly
    Christenson, Gwen
    Curtis, Nancy
    Schwarz, Emily
    Savardekar, Himanshu
    Norman, Ruthann
    Kleiber, Barbara
    Wesolowski, Robert
    Otterson, Gregory Alan
    Verschraegen, Claire F.
    Carson, William Edgar
    Shah, Manisha H.
    Konda, Bhavana
    Owen, Dwight Hall
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
    Arrivi, Giulia
    Verrico, Monica
    Roberto, Michela
    Barchiesi, Giacomo
    Faggiano, Antongiulio
    Marchetti, Paolo
    Mazzuca, Federica
    Tomao, Silverio
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3507 - 3523
  • [5] FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs)
    Dal Buono, A.
    Merola, E.
    Delle Fave, G.
    Wiedenmann, B.
    Pavel, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 67 - 67
  • [6] Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects
    Koumarianou, Anna
    Kaltsas, Gregory
    Kulke, Matthew H.
    Oberg, Kjell
    Strosberg, Jonathan R.
    Spada, Francesca
    Galdy, Salvatore
    Barberis, Massimo
    Fumagalli, Caterina
    Berruti, Alfredo
    Fazio, Nicola
    NEUROENDOCRINOLOGY, 2015, 101 (04) : 274 - 288
  • [7] Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?
    Velez, Maria A.
    Garon, Edward B.
    CLINICAL CANCER RESEARCH, 2023, 29 (04) : 691 - 693
  • [8] Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms
    Al-Toubah, Taymeyah
    Morse, Brian
    Strosberg, Jonathan
    PANCREAS, 2020, 49 (03) : 461 - 462
  • [9] Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms
    Al-Toubah, Taymeyah
    Morse, Brian
    Strosberg, Jonathan
    ONCOLOGIST, 2020, 25 (01): : E48 - E52
  • [10] Efficacy and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms
    Chatzellis, E.
    Angelousi, A.
    Daskalakis, K.
    Tsoli, M.
    Alexandraki, K.
    Wachula, E.
    Gross, D. J.
    Meirovitz, A.
    Grozinsky-Glasberg, S.
    Kos-Kudla, B.
    Koumarianou, A.
    Kaltsas, G.
    NEUROENDOCRINOLOGY, 2019, 108 : 146 - 146
12345